感染症治療藥的合夥交易•合作動向 是由出版商Pharmalicensing Ltd.在2006年04月所出版的。
這份英文市場調查報告書包含1476 pages 價格從美金2495起跳。
在全球保健領域之產品策略與事業拓展諮詢上,經驗豐富的英國市調公司 Pharmalicensing (總公司:約克州),詳盡地調查與分析感染症治療藥的合夥交易•合作動向,並出版綜合報告書 "Partneringdesk Deals and alliances in infectious diseases" 。
此報告書在下面的內容裡,不僅說明2001年1月至2006年3月感染症治療藥1,600件合夥交易及合作動向,也探討現今活動中的合夥動向、競爭分析及基準、主要25家企業的檔案等。
說明
第1章 各企業的交易概要
第2章 各開發階段的交易概要
第3章 交易種類
第4章 產業領域
第5章 主要25家企業的檔案
- 過去5年內治療領域的主要企業檔案
- 企業概要
- 產業策略
- 合夥策略
- 研究開發
- 歷史
- Abbott Laboratories
- Aventis
- Beckman Coulter Inc
- Boehringer Ingelheim GmbH
- Calypte Biomedical Corp
- Cangene
- CEL-SCI Corp
- Centers for Disease Control and Prevention
- Chiron Corp
- CombiMatrix
- Corixa
- Crucell
- Gilead Sciences Inc
- GlaxoSmithKline
- Hemispherx BioPharma Inc
- InterMune
- International AIDS Vaccine Initiative
- Medicines for Malaria Venture
- Merck & Co Inc
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Roche
- US Army Medical Research Institute of Infectious Diseases
- VaxGen Inc
- ViroLogic
第6章 交易、合作的詳細情報
- 2001年1月至2006年3月的交易概要
- 財務情報
用語
圖
- 圖1:2001年至2005年的交易
- 圖2:2005年的交易
- 圖3:每年的感染症治療藥交易
- 圖4:各開發階段(初期)感染症治療藥的交易
- 圖5:各開發階段(中期)感染症治療藥的交易
- 圖6:各開發階段(後期)感染症治療藥的交易
- 圖7:各類感染症治療藥的交易
- 圖8:各產業領域的感染症治療藥交易
Abstract
Partneringdesk Deals and alliances in infectious diseases
Partneringdesk deals and alliances in infectious diseases provides an in-depth
view of over 1600 deals and alliances announced in infectious diseases between
2001 and 2006, in a clear and accessible PDF format.
Introduction
A diagrammatical and analytical summary of the deals and dealmakers in the
therapy area over a five-year period.
Chapter 1: Deals by company
A comprehensive overview listing deals by company, with a full index of all
the deals announced. A clear and easy way to see the activities of any company.
Chapter 2: Deals by development stage
A review of deals by stage of development. Appreciate how deal values change
from discovery to launch in the therapy area.
Chapter 3: Deal type
Access deal information by type of transaction - see who is licensing or
partnering and using what type of deal.
Chapter 4: Industry sector
Deal announcements sorted by industry sector. Choose from nine sectors.
Chapter 5: Top 25 company profiles
Summary profiles for the most active companies in the therapy area over the
past five years, including contact details, business strategy, partnering
strategy, R&D and history.
Chapter 6: Detailed listing of deals and alliances
A full index of all the deals announced between Jan 2001 and Mar 2006. Every
deal entry includes a detailed deal description and financial information
where disclosed, such as headline values, upfront and milestone payments.
Every deal entry includes a detailed deal description and financial
information where disclosed, such as headline values, upfront and milestone
payments, and links to the full deal in the deal listing at the rear of each
report.
Table of Contents
Introduction
About Partneringdesk deals and alliances
Chapter 1: Deals in infectious diseases by company
Chapter 2: Deals in infectious diseases by development stage
Chapter 3: Deals in infectious diseases by type
Chapter 4: Deals in infectious diseases by industry sector
Chapter 5: Summary profiles for the most active companies in infectious
diseases
Chapter 6: List of deals
Glossary